Literature DB >> 30737079

Congenital disorder of glycosylation type 1T with a novel truncated homozygous mutation in PGM1 gene and literature review.

Wo-Tu Tian1, Xing-Hua Luan1, Hai-Yan Zhou1, Chao Zhang1, Xiao-Jun Huang1, Xiao-Li Liu2, Sheng-Di Chen1, Hui-Dong Tang3, Li Cao4.   

Abstract

The congenital disorders of glycosylation are a group of clinically and biochemically heterogeneous diseases characterized by multisystem involvement due to glycosylation defect of protein and lipid. Here we report a 49-year-old man with exercise-induced fatigue and pain of muscle, tachypnea, cleft palate and bifid uvula. Exercise induced elevation of serum creatine kinase (CK), ammonia and lactic acid was recorded. The abnormal levels of myoglobin, CK-MB and LDH as well as S-T elevation in electrocardiogram were observed in repeated hospitalization recordings. Electromyography showed myopathic damage. Repetitive nerve stimulation test of low rates showed decrement in the left deltoid muscle. He was identified with a novel homozygous frameshift variant in Phosphoglucomutase type 1 gene (c.405delT p.N135Kfs*9) by whole exome sequencing. Muscle biopsy exhibited minimal variation in fiber size without abnormal glycogen accumulation. Compared with controls', the patient's sample showed no signal at ∼61 kDa using N- or C-terminus antibody of Phosphoglucomutase type 1 in western blotting. A signal at ∼20 kDa was detected in patient using N-terminus antibody. Immunofluorescence revealed trace expression of C-terminus and a much lower expression of N-terminus on the sarcolemma than normal. Our findings indicate that c.405delT encodes a truncated protein with abnormal distribution and expression in skeletal muscle. In conclusion, genes associated with congenital disorders of glycosylation should be analyzed in patients with maxillofacial dysplasia, exertional weakness, cardiac involvement and exercise-induced-ammoniemia, without glycogen storage in skeletal muscle.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Congenital disorder of glycosylation; Glycogen storage disease; PGM1; Whole exome sequencing

Mesh:

Substances:

Year:  2019        PMID: 30737079     DOI: 10.1016/j.nmd.2019.01.001

Source DB:  PubMed          Journal:  Neuromuscul Disord        ISSN: 0960-8966            Impact factor:   4.296


  2 in total

1.  PGM1 suppresses colorectal cancer cell migration and invasion by regulating the PI3K/AKT pathway.

Authors:  Zhewen Zheng; Xue Zhang; Jian Bai; Long Long; Di Liu; Yunfeng Zhou
Journal:  Cancer Cell Int       Date:  2022-05-25       Impact factor: 6.429

Review 2.  International consensus guidelines for phosphoglucomutase 1 deficiency (PGM1-CDG): Diagnosis, follow-up, and management.

Authors:  Ruqaiah Altassan; Silvia Radenkovic; Andrew C Edmondson; Rita Barone; Sandra Brasil; Anna Cechova; David Coman; Sarah Donoghue; Kristina Falkenstein; Vanessa Ferreira; Carlos Ferreira; Agata Fiumara; Rita Francisco; Hudson Freeze; Stephanie Grunewald; Tomas Honzik; Jaak Jaeken; Donna Krasnewich; Christina Lam; Joy Lee; Dirk Lefeber; Dorinda Marques-da-Silva; Carlota Pascoal; Dulce Quelhas; Kimiyo M Raymond; Daisy Rymen; Malgorzata Seroczynska; Mercedes Serrano; Jolanta Sykut-Cegielska; Christian Thiel; Frederic Tort; Mari-Anne Vals; Paula Videira; Nicol Voermans; Peter Witters; Eva Morava
Journal:  J Inherit Metab Dis       Date:  2020-09-15       Impact factor: 4.982

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.